{"groups":[{"description":"Patients receive busulfan IV over 2 hours every 6 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.\n\nbusulfan: Given IV\n\ncyclophosphamide: Given IV","id":"FG000","title":"BuCy"},{"description":"Patients receive cyclophosphamide IV over 2 hours on days -5 and -4 and total-body irradiation (TBI) twice daily on days -3 to -1.\n\ncyclophosphamide: Given IV\n\ntotal-body irradiation: Given twice daily for 3 days","id":"FG001","title":"CyTBI"},{"description":"Patients receive fludarabine IV over 30 minutes on days -6 to -2 and melphalan IV over 1 hour on days -3 and -2.\n\nfludarabine phosphate: Given IV\n\nmelphalan: Given IV","id":"FG002","title":"FluMel"},{"description":"Patients receive etoposide IV over 26 hours beginning on day -5, cyclophosphamide IV over 2 hours on day -4, and TBI twice daily on days -3 to -1.\n\ncyclophosphamide: Given IV\n\netoposide: Given IV\n\ntotal-body irradiation: Given twice daily for 3 days","id":"FG003","title":"VpCyTBI"},{"description":"Patients receive cyclophosphamide IV over 2 hours on days -5 and -4, TBI twice daily on days -3 to -1, and anti-thymocyte globulin IV over 4-8 hours on days -3 to -1. OR Patients receive cyclophosphamide IV over 2 hours on days -5 to -2 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -3. OR Patients receive cyclophosphamide IV over 24 hours, carboplatin IV over 24 hours, and thiotepa IV over 24 hours on days -7 to -4. OR Patients receive fludarabine IV over 30 minutes on days -5 to -1 and anti-thymocyte globulin IV over 4-8 hours on days -5 to -2. OR Patients receive busulfan IV over 2 hours every 6 hours and anti-thymocyte globulin IV over 4-8 hours on days -7 to -4 and cyclophosphamide IV over 2 hours on days -3 and -2.","id":"FG004","title":"Other"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"55"},{"groupId":"FG001","numSubjects":"69"},{"groupId":"FG002","numSubjects":"199"},{"groupId":"FG003","numSubjects":"23"},{"groupId":"FG004","numSubjects":"15"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"55"},{"groupId":"FG001","numSubjects":"69"},{"groupId":"FG002","numSubjects":"199"},{"groupId":"FG003","numSubjects":"23"},{"groupId":"FG004","numSubjects":"15"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}